Approval · Notice of Compliance 25773 · 2021
ZEVTERA: Notice of Compliance 25773
Issued April 30, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25773
- Date
- April 30, 2021
- Company
- Avir Pharma IncBlainville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional drug product manufacturing site. revisions to the labels and package insert
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZEVTERA | Not yet assigned | — |
Medicinal ingredients
- CEFTOBIPROLE MEDOCARIL 500 MG per VIAL